BORTEZOMIB-BASED THERAPY IN FRAIL MULTIPLE MYELOMA PATIENTS

被引：0
|
作者：
Antonioli, E.
Staderini, M.
Nozzoli, C.
Bacchiarri, F.
Barone, F.
Grieco, P.
Coltro, G.
Guarrera, A.
Messeri, M.
Bosi, A.
机构：
[1] Azienda Osped Univ Careggi, SODC Ematol, Careggi, Italy
[2] Azienda Osped Univ Careggi, SOD Terapie Cellulari & Med Trasfus, Careggi, Italy
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P202
引用
收藏
页码：132 / 132
页数：1
相关论文
共 50 条
  • [21] The effect of bortezomib monotherapy and bortezomib-based regimens on bone metabolism in patients with relapsed/refractory multiple myeloma
    Terpos, E.
    Heath, D. J.
    Zervas, K.
    Anagnostopoulos, A.
    Katodritou, E.
    Christoulas, D.
    Pouli, A.
    Chantry, A.
    Anargyrou, K.
    Kastritis, E.
    Verrou, E.
    Tsionos, K.
    Croucher, P.
    Dimopoulus, M. A.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 133 - 134
  • [22] CMV REACTIVATION IN MULTIPLE MYELOMA TREATED WITH BORTEZOMIB-BASED REGIMENS
    Sampath, V. S.
    Yee, A. Tso Ching
    Lee, L. K.
    Fong, S. Z.
    Lim, Y. C.
    Ponnudurai, K.
    Rajendran, J.
    Ong, K. H.
    [J]. HAEMATOLOGICA, 2014, 99 : 752 - 752
  • [23] Efficacy and safety of reduced-intensity induction therapy with a bortezomib-based regimen in elderly patients with multiple myeloma
    Sopena, Maria
    Clavero, Estela Martin
    Villa, Paula
    Martinez-Lopez, Joaquin
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (03) : 147 - 154
  • [24] Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving bortezomib-based therapy for multiple myeloma
    Zhou, Xin
    Wang, Jing
    Xia, Jun
    Cheng, Feng
    Mao, Jingjue
    Zhu, Jianwei
    Guo, Hongfeng
    [J]. CANCER BIOMARKERS, 2018, 22 (01) : 43 - 48
  • [25] Bortezomib-based Triplet Regimens for Remission Induction in Multiple Myeloma
    Toor, Saima Humayun
    Satti, Tariq Mahmood
    Iftikhar, Raheel
    Mahmood, Syed Kamran
    Shamshad, Ghassan Umair
    Rehman, Jahanzeb Ur
    [J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (05): : 527 - 531
  • [26] An Economic Evaluation of Bortezomib-Based Induction Therapy in Double Transplant Protocols for Newly Diagnosed Multiple Myeloma Patients
    Wang, Si-Tien
    Duh, Mei Sheng
    Huang, Hui
    White, Leigh Ann
    Chang, Eva
    Esseltine, Dixie-Lee
    Marantz, Jing L.
    [J]. BLOOD, 2008, 112 (11) : 831 - 832
  • [27] Comparative proteomic profiling of sera from patients with refractory multiple myeloma for predicting response to bortezomib-based therapy
    Luczak, Magdalena
    Kubicki, Tadeusz
    Rzetelska, Zuzanna
    Szczepaniak, Tomasz
    Przybylowicz-Chalecka, Anna
    Ratajczak, Blazej
    Czerwinska-Rybak, Joanna
    Nowicki, Adam
    Joks, Monika
    Jakubowiak, Andrzej
    Komarnicki, Mieczyslaw
    Dytfeld, Dominik
    [J]. POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2017, 127 (06): : 392 - 400
  • [28] Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma
    Bumma, Naresh
    Dhakal, Binod
    Fraser, Raphael
    Estrada-Merly, Noel
    Anderson, Kenneth
    Freytes, Cesar O.
    Hildebrandt, Gerhard C.
    Holmberg, Leona
    Krem, Maxwell M.
    Lee, Cindy
    Lekakis, Lazaros
    Lazarus, Hillard M.
    Mian, Hira
    Murthy, Hemant S.
    Nathan, Sunita
    Nishihori, Taiga
    Parrondo, Ricardo
    Patel, Sagar S.
    Solh, Melhem
    Strouse, Christopher
    Vesole, David H.
    Kumar, Shaji
    Qazilbash, Muzaffar H.
    Shah, Nina
    D'Souza, Anita
    Sidana, Surbhi
    [J]. CANCER, 2023, 129 (14) : 2179 - 2191
  • [29] New bortezomib-based combination therapy for elimination of myeloma cells
    S Meister
    V Lang
    TT Wissniowski
    RE Voll
    [J]. Cell Communication and Signaling, 7 (Suppl 1)
  • [30] Evaluation of neutrophil-to-lymphocyte ratio in newly diagnosed patients receiving bortezomib-based therapy for multiple myeloma
    Zhou, Xin
    Wang, Jing
    Xia, Jun
    Cheng, Feng
    Mao, Jingjue
    Zhu, Jianwei
    Guo, Hongfeng
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 42 : S5 - S5
12345